Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04195139
Title Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM (NUTMEG)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Sydney
Indications

glioblastoma

high grade glioma

gliosarcoma

Therapies

Nivolumab + Temozolomide

Temozolomide

Age Groups: senior
Covered Countries USA


No variant requirements are available.